标题
BRAF inhibitors in BRAF-V600 mutated primary neuroepithelial brain tumors
作者
关键词
-
出版物
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 25, Issue 1, Pages 7-14
出版商
Informa Healthcare
发表日期
2015-11-05
DOI
10.1517/13543784.2016.1110143
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Successful Treatment of a ProgressiveBRAFV600E–Mutated Anaplastic Pleomorphic Xanthoastrocytoma With Vemurafenib Monotherapy
- (2016) Eudocia Q. Lee et al. JOURNAL OF CLINICAL ONCOLOGY
- BRAF VE1 Immunoreactivity Patterns in Epithelioid Glioblastomas Positive for BRAF V600E Mutation
- (2015) Bette K. Kleinschmidt-DeMasters et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Radiosensitization by BRAF inhibitor therapy--mechanism and frequency of toxicity in melanoma patients
- (2015) M. Hecht et al. ANNALS OF ONCOLOGY
- Pilot Trial of Combined BRAF and EGFR Inhibition in BRAF-Mutant Metastatic Colorectal Cancer Patients
- (2015) R. Yaeger et al. CLINICAL CANCER RESEARCH
- Response to dabrafenib after progression on vemurafenib in a patient with advanced BRAF V600E-mutant bronchial adenocarcinoma
- (2015) S. Schmid et al. LUNG CANCER
- What is the optimal use of bevacizumab in glioblastoma?
- (2015) Annick Desjardins Nature Reviews Neurology
- A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study
- (2015) J. Schuster et al. NEURO-ONCOLOGY
- 107 ReACT
- (2015) David A. Reardon et al. NEUROSURGERY
- Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations
- (2015) David M. Hyman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- A Retrospective Evaluation of Vemurafenib as Treatment for BRAF-Mutant Melanoma Brain Metastases
- (2015) J. J. Harding et al. ONCOLOGIST
- BRAF Overexpression Induces Rampant Glioma Proliferation Independent of Phospho-EGFR Expression**
- (2015) Mei Li et al. Advances in Clinical and Experimental Medicine
- Complete clinical regression of a BRAF V600E-mutant pediatric glioblastoma multiforme after BRAF inhibitor therapy
- (2014) Giles W Robinson et al. BMC CANCER
- A Single-Arm, Open-Label, Expanded Access Study of Vemurafenib in Patients With Metastatic Melanoma in the United States
- (2014) Lawrence Flaherty et al. CANCER JOURNAL
- BRAF alterations in brain tumours
- (2014) Anna Sophie Berghoff et al. CURRENT OPINION IN NEUROLOGY
- Successful Treatment With Dabrafenib (GSK2118436) in a Patient With Ganglioglioma
- (2014) Kent C. Shih et al. JOURNAL OF CLINICAL ONCOLOGY
- Pediatric posterior fossa ganglioglioma: unique MRI features and correlation with BRAF V600E mutation status
- (2014) Aaron J. Lindsay et al. JOURNAL OF NEURO-ONCOLOGY
- Response of recurrent BRAFV600E mutated ganglioglioma to Vemurafenib as single agent
- (2014) Francesca del Bufalo et al. Journal of Translational Medicine
- Safety and efficacy of vemurafenib in BRAFV600E and BRAFV600K mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study
- (2014) Grant A McArthur et al. LANCET ONCOLOGY
- EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma
- (2014) Michael Weller et al. LANCET ONCOLOGY
- Vemurafenib in patients with BRAFV600 mutated metastatic melanoma: an open-label, multicentre, safety study
- (2014) James Larkin et al. LANCET ONCOLOGY
- Oncogenic BRAF inhibitor UAI-201 induces cell cycle arrest and autophagy in BRAF mutant glioma cells
- (2014) Jun-Ho Ahn et al. LIFE SCIENCES
- BRAF V600E-mutated lung adenocarcinoma with metastases to the brain responding to treatment with vemurafenib
- (2014) Sara D. Robinson et al. LUNG CANCER
- CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011
- (2014) Q. T. Ostrom et al. NEURO-ONCOLOGY
- Pilomyxoid astrocytoma treated successfully with vemurafenib
- (2014) Mary Skrypek et al. PEDIATRIC BLOOD & CANCER
- Vemurafenib-Induced Neutrophilic Panniculitis in a Child with a Brainstem Glioma
- (2014) Emily S. West et al. PEDIATRIC DERMATOLOGY
- Analysis of the BRAFV600E Mutation in Central Nervous System Tumors
- (2014) Jae Kyung Myung et al. Translational Oncology
- Mutant BRAF V600E protein in ganglioglioma is predominantly expressed by neuronal tumor cells
- (2013) Christian Koelsche et al. ACTA NEUROPATHOLOGICA
- Dysembryoplastic Neuroepithelial Tumors Share with Pleomorphic Xanthoastrocytomas and Gangliogliomas BRAFV600EMutation and Expression
- (2013) Céline Chappé et al. BRAIN PATHOLOGY
- Pediatric Brainstem Gangliogliomas ShowBRAFV600EMutation in a High Percentage of Cases
- (2013) Andrew M. Donson et al. BRAIN PATHOLOGY
- BRAF-Mutated Pleomorphic Xanthoastrocytoma is Associated with Temporal Location, Reticulin Fiber Deposition and CD34 Expression
- (2013) Christian Koelsche et al. BRAIN PATHOLOGY
- Intratumoral Heterogeneity of Genomic Imbalance in a Case of Epithelioid Glioblastoma withBRAFV600E Mutation
- (2013) Sumihito Nobusawa et al. BRAIN PATHOLOGY
- The Somatic Genomic Landscape of Glioblastoma
- (2013) Cameron W. Brennan et al. CELL
- Vemurafenib in patients with BRAFV600 mutation-positive melanoma with symptomatic brain metastases: Final results of an open-label pilot study
- (2013) Reinhard Dummer et al. EUROPEAN JOURNAL OF CANCER
- Brainstem Ganglioglioma Successfully Treated With Vemurafenib
- (2013) Sarah Rush et al. JOURNAL OF CLINICAL ONCOLOGY
- BRAF alterations in pediatric low grade gliomas and mixed neuronal–glial tumors
- (2013) Efthymios Dimitriadis et al. JOURNAL OF NEURO-ONCOLOGY
- Salvage therapy with BRAF inhibitors for recurrent pleomorphic xanthoastrocytoma: a retrospective case series
- (2013) Marc C. Chamberlain JOURNAL OF NEURO-ONCOLOGY
- BRAF-V600E mutation in pediatric and adult glioblastoma
- (2013) S. Dahiya et al. NEURO-ONCOLOGY
- BRAF V600E expression and distribution in desmoplastic infantile astrocytoma/ganglioglioma
- (2013) C. Koelsche et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Vemurafenib in pediatric patients withBRAFV600Emutated high-grade gliomas
- (2013) Francisco Bautista et al. PEDIATRIC BLOOD & CANCER
- Immunohistochemical Detection of the BRAF V600E-mutated Protein in Papillary Thyroid Carcinoma
- (2012) Oskar Koperek et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Immunohistochemistry Is Highly Sensitive and Specific for the Detection of V600E BRAF Mutation in Melanoma
- (2012) Georgina V. Long et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Clinical neuropathology practice news 2-2012: BRAF V600E testing
- (2012) David Capper et al. CLINICAL NEUROPATHOLOGY
- Anaplastic PXA in adults: case series with clinicopathologic and molecular features
- (2012) Yao Schmidt et al. JOURNAL OF NEURO-ONCOLOGY
- Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial
- (2012) Gerald S Falchook et al. LANCET
- Survival in BRAF V600–Mutant Advanced Melanoma Treated with Vemurafenib
- (2012) Jeffrey A. Sosman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunohistochemical testing of BRAF V600E status in 1,120 tumor tissue samples of patients with brain metastases
- (2011) David Capper et al. ACTA NEUROPATHOLOGICA
- Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody
- (2011) David Capper et al. ACTA NEUROPATHOLOGICA
- Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma
- (2011) Genevieve Schindler et al. ACTA NEUROPATHOLOGICA
- Targeted Therapy for BRAFV600E Malignant Astrocytoma
- (2011) T. P. Nicolaides et al. CLINICAL CANCER RESEARCH
- BRAFAlterations in Primary Glial and Glioneuronal Neoplasms of the Central Nervous System With Identification of 2 Novel KIAA1549
- (2011) Alex Lin et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- BRAF V600E Mutations Are Common in Pleomorphic Xanthoastrocytoma: Diagnostic and Therapeutic Implications
- (2011) Dora Dias-Santagata et al. PLoS One
- Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma
- (2010) Houtan Noushmehr et al. CANCER CELL
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
- (2010) Roel G.W. Verhaak et al. CANCER CELL
- Guidelines on management of low-grade gliomas: report of an EFNS-EANO* Task Force
- (2010) R. Soffietti et al. EUROPEAN JOURNAL OF NEUROLOGY
- Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma
- (2009) Andrey Korshunov et al. ACTA NEUROPATHOLOGICA
- Tandem Duplication Producing a Novel OncogenicBRAFFusion Gene Defines the Majority of Pilocytic Astrocytomas
- (2008) David T.W. Jones et al. CANCER RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started